You just read:

Immunic, Inc. to Present Selected Available and Previously Unpublished Data Regarding Lead Program, IMU-838, at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis 2019

News provided by

Immunic, Inc.

Sep 11, 2019, 06:30 ET